Timothy G Murray Selected Research

Phacoemulsification

1/2023	Clinical Outcomes of Combined Phacoemulsification With Intraocular Lens Placement and Microincision Vitrectomy in Adult Vitreoretinal Disease.
1/2015	Clinical findings and genetic expression profiling of three pigmented lesions of the optic nerve.
3/2014	Spectral-domain optical coherence tomography evaluation of choroidal melanoma and nevus fine-needle aspiration biopsy incision sites.
1/2014	Phacovitrectomy.
1/2012	Intraoperative intravitreal triamcinolone decreases macular edema after vitrectomy with phacoemulsification.
1/2012	Ocular hypertension after intravitreal triamcinolone with vitrectomy and phacoemulsification.
8/2010	Combined phacoemulsification and sutureless 23-gauge pars plana vitrectomy for complex vitreoretinal diseases.
10/2008	Tumor volume reduction using combined phacoemulsification and intravitreal triamcinolone injection for the management of cataract with treated uveal melanoma and atypical nevi.
9/2003	Combined pars plana vitrectomy and lens management in complex vitreoretinal disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Timothy G Murray Research Topics

Disease

56	Neoplasms (Cancer) 11/2022 - 12/2002
48	Retinoblastoma (Glioblastoma, Retinal) 05/2022 - 03/2002
18	Cataract (Cataracts) 01/2023 - 01/2002
18	Retinal Detachment (Retinal Detachments) 01/2022 - 10/2002
17	Melanoma (Melanoma, Malignant) 01/2023 - 12/2002
16	Endophthalmitis (Ophthalmia) 01/2021 - 02/2003
16	Retinal Neoplasms 05/2013 - 04/2006
15	Macular Edema 03/2022 - 04/2003
13	Uveal melanoma 07/2021 - 10/2003
12	Macular Degeneration (Age-Related Maculopathy) 07/2022 - 01/2002
9	Retinal Telangiectasis 05/2021 - 11/2005
7	Hemorrhage 07/2020 - 08/2003
6	Hemangioma (Angioma) 01/2023 - 01/2004
6	Retinopathy of Prematurity (Retrolental Fibroplasia) 01/2022 - 03/2006
6	Hypoxia (Hypoxemia) 05/2021 - 12/2009
6	Wounds and Injuries (Trauma) 09/2009 - 04/2005
5	Neoplasm Metastasis (Metastasis) 07/2022 - 03/2005
5	Glaucoma 05/2020 - 11/2007
5	Retinal Perforations 01/2017 - 10/2002
4	Inflammation (Inflammations) 07/2021 - 07/2020
4	Retinal Vasculitis 07/2021 - 07/2009
4	Retinal Vein Occlusion 01/2010 - 10/2006
4	Corneal Edema 08/2007 - 10/2002
3	Toxic Optic Neuropathy 07/2022 - 10/2004
3	Choroidal Neovascularization 01/2019 - 02/2002
3	von Hippel-Lindau Disease (von Hippel Lindau Disease) 01/2016 - 01/2004
3	Disease Progression 02/2013 - 07/2009
3	Atrophy 01/2013 - 02/2002
3	Proliferative Vitreoretinopathy 03/2010 - 10/2002
2	Edema (Dropsy) 09/2020 - 04/2015
2	Choroidal Effusions 07/2020 - 08/2003
2	Aphakia 05/2020 - 08/2003
2	Ocular Hypertension (Glaucoma, Suspect) 01/2017 - 01/2012
2	Capillary Hemangioma 01/2016 - 01/2004
2	Familial Exudative Vitreoretinopathies 12/2015 - 11/2004
2	Choroid Diseases 12/2015 - 11/2010
2	Fibrosis (Cirrhosis) 01/2014 - 08/2007
2	Nevus (Nevi) 01/2014 - 10/2008
2	Ischemia 01/2014 - 03/2008
2	Telangiectasis (Telangiectasia) 01/2014 - 11/2005
2	Hemangioblastoma 09/2010 - 01/2009
2	Vitreous Hemorrhage 07/2009 - 01/2002
2	Necrosis 12/2007 - 07/2003
1	Intraoperative Complications 01/2023
1	Carcinoma (Carcinomatosis) 07/2022

Drug/Important Bio-Agent (IBA)

23	Bevacizumab (Avastin)FDA Link 05/2021 - 03/2008
21	Retinaldehyde (Retinal)IBA 01/2023 - 10/2002
15	beta Subunit Luteinizing HormoneIBA 02/2012 - 04/2006
13	Carboplatin (JM8)FDA LinkGeneric 12/2010 - 02/2004
9	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 07/2021 - 11/2003
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 07/2010
7	Anti-Bacterial Agents (Antibiotics)IBA 07/2021 - 04/2003
7	Triamcinolone (Aristocort)FDA Link 05/2021 - 02/2003
7	Melphalan (Alkeran)FDA LinkGeneric 06/2015 - 04/2010
6	Deoxyglucose (2 Deoxy D glucose)IBA 02/2016 - 07/2008
5	brolucizumabIBA 07/2021 - 07/2020
5	IodineIBA 01/2020 - 12/2002
4	Iodine-125IBA 06/2013 - 01/2012
4	anecortave acetateIBA 01/2011 - 04/2006
3	afliberceptIBA 05/2021 - 01/2019
3	pimonidazoleIBA 12/2010 - 07/2008
3	Angiogenesis InhibitorsIBA 06/2010 - 04/2006
3	perfluorooctaneIBA 03/2010 - 10/2002
2	Capsules (Microcapsules)IBA 01/2023 - 09/2007
2	Retinal Pigments (Pigments, Visual)IBA 05/2021 - 01/2013
2	Fluorescein (Funduscein)FDA LinkGeneric 01/2021 - 01/2019
2	Glucose (Dextrose)FDA LinkGeneric 02/2016 - 02/2014
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2016 - 09/2006
2	Protein Isoforms (Isoforms)IBA 02/2014 - 12/2008
2	Eosine Yellowish-(YS) (Eosin)IBA 02/2012 - 01/2009
2	Hematoxylin (Haematoxylon)IBA 02/2012 - 01/2009
2	SteroidsIBA 01/2012 - 01/2009
2	Ranibizumab (Lucentis)FDA Link 04/2011 - 09/2009
2	Vincristine (Oncovin)FDA LinkGeneric 01/2010 - 01/2009
2	Proteins (Proteins, Gene)FDA Link 07/2009 - 03/2005
2	Silicone OilsIBA 04/2005 - 09/2003
1	erdafitinibIBA 07/2022

Therapy/Procedure

38	Therapeutics 03/2022 - 07/2003
32	Drug Therapy (Chemotherapy) 11/2022 - 07/2003
27	Vitrectomy 01/2023 - 01/2002
18	Lasers (Laser) 01/2022 - 02/2002
17	Injections 12/2015 - 01/2005
16	Radiotherapy 07/2021 - 03/2002
13	Brachytherapy 09/2021 - 12/2002
12	Intravitreal Injections 01/2021 - 02/2003
11	Laser Therapy (Surgery, Laser) 03/2022 - 03/2006
9	Phacoemulsification 01/2023 - 09/2003
9	Semiconductor Lasers 09/2020 - 11/2005
8	Intraocular Lenses (Intraocular Lens) 01/2023 - 01/2002
8	Aftercare (After-Treatment) 07/2020 - 10/2005
5	Light Coagulation 05/2021 - 07/2004
4	Anesthesia 01/2019 - 07/2012
4	Intraocular Lens Implantation 01/2015 - 09/2003
4	Photochemotherapy (Photodynamic Therapy) 01/2014 - 07/2004
4	Cataract Extraction 10/2013 - 01/2002
3	Intraocular Injections 04/2010 - 04/2006
2	Immunotherapy 12/2021 - 05/2007
2	Palliative Care (Palliative Therapy) 09/2021 - 12/2017
2	Off-Label Use 01/2021 - 03/2008
2	Salvage Therapy 03/2008 - 02/2004